Puma Biotechnology Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Puma Biotech (PBYI) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY24 Revenue Guidance
August 1, 2024 4:44 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $44.4 million versus the consensus estimate of $47.3 million.
GUIDANCE:
Puma Biotech sees FY2024 revenue of $183-190 million, versus the consensus... More



